Advertisement

InFo Onkologie

, Volume 21, Issue 2, pp 39–49 | Cite as

Chancen auf mehr als nur eine kurzfristige Palliation

Erneute Strahlentherapie bei Tumorrezidiven

  • Frank Zimmermann
zertifizierte fortbildung
  • 53 Downloads

Zusammenfassung

Nahezu die Hälfte der Patienten mit lokal fortgeschrittenen Tumorerkrankungen entwickelt nach initial erfolgreicher Therapie lokale Rezidive. Eine Heilung ist dann zumeist nicht mehr möglich, wohl aber eine gute Palliation. Dabei müssen für die Re-Bestrahlung die Vorteile gegen die Nachteile (etwa ein erhöhtes Risiko für Nebenwirkungen) sorgfältig abgewogen werden.

Literatur

  1. 1.
    Zhou YQ et al. Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer. Medicine (Baltimore). 2018;97(5):e9777.CrossRefGoogle Scholar
  2. 2.
    Chen Y et al. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone. Dis Esophagus. 2014;27(2):134–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Janot F et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008;26(34):5518–23.CrossRefPubMedGoogle Scholar
  4. 4.
    Merlotti A et al. What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria. Crit Rev Oncol Hematol. 2017;111:20–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Spencer SA et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluoruracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001;51(5):1299–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Langer CJ et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamouc cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007;25(30):4800–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Tortochaux J et al. Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexat in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent. Radiother Oncol. 2011;100(1):70–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Baliga S et al. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review. Head Neck. 2017;39(3):595–601.CrossRefPubMedGoogle Scholar
  9. 9.
    Heron DE et al. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol. 2011;34(2):165–72.PubMedGoogle Scholar
  10. 10.
    Vargo JA et al. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2015;91(3):480–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Ling DC et al. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016;95(3):973–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Strojan P et al. Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck. 2013;35(1):123–32.CrossRefPubMedGoogle Scholar
  13. 13.
    Høyer M. Re-irradiation with stereotactic body radiation therapy (SBRT). Chin Clin Oncol. 2017;6(Suppl 2):S15.CrossRefPubMedGoogle Scholar
  14. 14.
    Evans T et al. Special topics in immunotherapy and radiation therapy: reirradiation and palliation. Transl Lung Cancer Res. 2017;6(2):119–30.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Drudge CS et al. Thoracic reirradiation for lung cancer: a literature review and practical guide. Ann Palliat Med. 2014;3(2):75–91.Google Scholar
  16. 16.
    Noble J et al. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol. 2006;1(9):1042–58.CrossRefPubMedGoogle Scholar
  17. 17.
    Binkley MS et al. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. Int J Radiat Oncol Biol Phys. 2016;94(4):808–15.CrossRefPubMedGoogle Scholar
  18. 18.
    De Ruysscher D et al. High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol. 2014;15(13):e620–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Marta GN et al. Reirradiation for locally recurrent breast cancer. Breast. 2017;33:159–65.CrossRefPubMedGoogle Scholar
  20. 20.
    Wadasadawala T et al. Management of Isolated Locoregional Recurrences in Breast Cancer: A review of Local and Systemic Modalities. Clin Breast Cancer. 2017;17(7):493–502.CrossRefPubMedGoogle Scholar
  21. 21.
    Gentilini O et al. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol. 2012;19(12):3771–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Harms W et al. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol. 2016;192(4):199–208.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Deutsch M. Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys. 2002;53(3):687–91.CrossRefPubMedGoogle Scholar
  24. 24.
    Trombetta M et al. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Am J Clin Oncol. 2009;32(3):314–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Guix B et al. Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys. 2010;78(3):804–10.CrossRefPubMedGoogle Scholar
  26. 26.
    Kauer-Dorner D et al. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol. 2012;102(1):96–101.CrossRefPubMedGoogle Scholar
  27. 27.
    Hannoun-Levi JM et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumor recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol. 2013;108(2):226–31.CrossRefPubMedGoogle Scholar
  28. 28.
    Harms W et al. Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences. Int J Radiat Oncol Biol Phys. 2001;49(1):205–10.CrossRefPubMedGoogle Scholar
  29. 29.
    Niehoff P et al. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Strahlenther Onkol. 2006;182(2):102–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Merino T et al. Re-irrdiation for locally recurrent refractory breast cancer. Oncotarget. 2015;6(33):35051–62.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Linthorst M et al. Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol. 2015;117(2):217–22.CrossRefPubMedGoogle Scholar
  32. 32.
    Myrehaug S et al. Re-irradiation of Vertebral Body Metastases: Treatment in the Radiosurgery Era. Clin Oncol (R Coll Radiol). 2018;30(2):85–92.CrossRefGoogle Scholar
  33. 33.
    Chiu N et al. Re-irradiation for painful bone metastases: evidence-based approach. Ann Palliat Med. 2015;4(4):214–9.PubMedGoogle Scholar
  34. 34.
    Chow R et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol. 2017;122(3):323–31.CrossRefPubMedGoogle Scholar
  35. 35.
    Chow E et al. Single versus multiple fractions of repeat radiation therapy for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. 2014;15(2):164–71.CrossRefPubMedGoogle Scholar
  36. 36.
    Myrehaug S et al. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. 2017;27(4):428–35.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Strahlentherapie und RadioonkologieUniversitätsspital BaselBaselSchweiz

Personalised recommendations